Bird Flu (H5N1 Avian Influenza) Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Morrisville's Fujifilm Diosynth acquires Texas A&M bioterror defense spinout
Fujifilm Diosynth Biotechnologies U.S.A. acquired nearly half of Kalon Biotherapeutics, expanding Fujifilm's vaccine and bioterror defense capacity. It subcontracts with the federal government through BARDA (the Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services) to protect public health in emergencies, including incidents of bioterrorism or an outbreak of pandemic influenza. Fujifilm acquired 49 percent of the total membership interests… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 19, 2014 Category: Biotechnology Authors: Jason deBruyn Source Type: news

Extraterrestrials on a Comet Are Faking Climate Change. Or Something
You’ve surely heard the exciting news that the European Space Agency successfully landed a small spacecraft on the surface of Comet 67P—or perhaps we should say “Comet 67P.” Because what you probably haven’t heard is that the ostensible comet is actually a spacecraft, that it has a transmitting tower and other artificial structures on its surface, and that the mission was actually launched to respond to a radio greeting from aliens that NASA received 20 years ago. Really, you can read it here in UFO Sightings Daily, and even watch a video that seals the deal if you have any doubt. None of this...
Source: TIME: Top Science and Health Stories - November 17, 2014 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized 9/11 aliens birthers comet 67p Conspiracy Theories esa extraterrestrials global warming hoax JFK NASA psychology Science truthers Source Type: news

November 2014
Preventing Type 2 Diabetes: Steps Toward a Healthier Life...Parkinson’s Disease: Understanding a Complicated Condition...Progress Toward a Bird Flu Vaccine...Participating in Alzheimer’s Research...Featured Web Site: Safe to Sleep (Source: NIH News in Health)
Source: NIH News in Health - November 1, 2014 Category: Consumer Health News Source Type: news

New step towards eradication of H5N1 bird flu
A new test has been developed that can distinguish between birds that have been vaccinated against the H5N1 strain of avian influenza virus or 'bird flu' with those that have been naturally infected. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 31, 2014 Category: Science Source Type: news

New step towards eradication of H5N1 bird flu
(University of Adelaide) A University of Adelaide-led project has developed a new test that can distinguish between birds that have been vaccinated against the H5N1 strain of avian influenza virus or 'bird flu' with those that have been naturally infected. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 31, 2014 Category: Infectious Diseases Source Type: news

Living With a Degree of Risk: Time for Action at Home
(Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 27, 2014 Category: Consumer Health News Source Type: news

Fujifilm says to buy U.S. vaccine maker as Ebola spreads
TOKYO (Reuters) - Japan's Fujifilm Holdings Corp said on Monday it would buy 49 percent of Texas-based Kalon Biotherapeutics LLC, which has expertise in manufacturing vaccines used against pandemic influenza, Ebola and other public-health threats. (Source: Reuters: Health)
Source: Reuters: Health - October 27, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Progress Toward an H7N9 Avian Flu Vaccine
An experimental vaccine against H7N9 avian influenza prompted substantial immune responses in 59% of volunteers. The approach could lead to improved flu vaccines. (Source: NIH Research Matters)
Source: NIH Research Matters - October 20, 2014 Category: Research Source Type: news

Scientists Aim to Improve Vaccines Against 'Bird Flu'
Title: Scientists Aim to Improve Vaccines Against 'Bird Flu'Category: Health NewsCreated: 10/7/2014 12:00:00 AMLast Editorial Review: 10/8/2014 12:00:00 AM (Source: MedicineNet Hepatitis C General)
Source: MedicineNet Hepatitis C General - October 8, 2014 Category: Infectious Diseases Source Type: news

Scientists Aim to Improve Vaccines Against 'Bird Flu'
Two studies show promising results Source: HealthDay Related MedlinePlus Pages: Bird Flu, Immunization (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 7, 2014 Category: Consumer Health News Source Type: news

H7N9 flu vaccine study shows adjuvant is essential for effective immune response
(Emory Health Sciences) A clinical trial of an experimental H7N9 avian influenza vaccine found an immune response believed to be protective in 59 percent of study participants who received two injections of inactivated vaccine at the lowest dosage tested when mixed with an adjuvant. Without the adjuvant, there was a minimal immune response. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 7, 2014 Category: Global & Universal Source Type: news

Candidate H7N9 avian flu vaccine works better with adjuvant
(NIH/National Institute of Allergy and Infectious Diseases) An experimental vaccine to protect people against H7N9 avian influenza prompted immune responses in 59 percent of volunteers who received two injections at the lowest dosage tested, but only if the vaccine was mixed with adjuvant -- substance that boosts the body's response to vaccination. Without adjuvant, immune responses produced by the investigational vaccine were minimal regardless of vaccine dosage, according to findings from a clinical trial sponsored by NIAID, part of NIH. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 7, 2014 Category: Infectious Diseases Source Type: news

Studies examine vaccination strategies for prevention, control of avian flu
(The JAMA Network Journals) Two randomized trials in the October 8 issue of JAMA examine new vaccination strategies for the prevention and control of avian influenza, often referred to as 'bird flu.' This is a theme issue on infectious disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 7, 2014 Category: Infectious Diseases Source Type: news

Novavax reports positive results from Phase I/II trial of H7N9 with Matrix-M
US-based biopharmaceutical firm Novavax has reported positive top-line results from a Phase I/II clinical trial of its H7N9 Avian Influenza virus-like particles (VLP) vaccine candidate (H7N9 VLP) with proprietary adjuvant Matrix-M. (Source: Drug Development Technology)
Source: Drug Development Technology - September 23, 2014 Category: Pharmaceuticals Source Type: news